Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CARP: PDT vs RFA for Hilar Cholangiocarcinoma
NCT05551299Phase 4Recruiting
- Sponsor
- Leipzig University
- Start
- Feb 2023
- Primary completion
- Apr 2028
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in hilar cholangiocarcinoma (HC), sponsored by Leipzig University. Primary endpoint: Overall Survival at 1 year. Started Feb 2023; status: recruiting.
02
Conditions
hilar cholangiocarcinoma (HC)
Beyond the preview
Go deeper on NCT05551299.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05551299.